Results 201 to 210 of about 113,305 (215)
Some of the next articles are maybe not open access.

In Vitro pharmacodynamics of CKD-602 in HT-29 cells

Archives of Pharmacal Research, 2002
Tae Moo Yoo   +2 more
exaly  

Apoptotic effect of CKD-602 (Camtobell®) on oral squamous cell carcinoma cell lines

Oral Oncology, 2009
Hoon Myoung   +2 more
exaly  

Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer

Gynecologic Oncology, 2008
Hyo-Pyo Lee   +2 more
exaly  

Embryotoxic effects of CKD-602, a new camptothecin anticancer agent, in rats

Reproductive Toxicology, 2005
Moon-Koo Chung, Jong-Choon Kim
exaly  

Phase I/IIa Study of Combination Chemotherapy with CKD‐602 and Cisplatin in Patients with Recurrent Epithelial Ovarian Cancer

Annals of the New York Academy of Sciences, 2009
Hyo-Cheol Kim   +2 more
exaly  

Contrasting effects of carbachol, McN-A-343 and AHR-602 on Ca2+ -mobilization and Ca2+ -influx pathways in taenia caeci

British Journal of Pharmacology, 1997
Shigeru Hishinuma   +2 more
exaly  

Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats

Regulatory Toxicology and Pharmacology, 2006
Jong-Choon Kim
exaly  

Effects of CKD-602, a New Camptothecin Anticancer Agent, on Pregnant Does and Embryo–Fetal Development in Rabbits

Drug and Chemical Toxicology, 2005
Moon-Koo Chung, Jong-Choon Kim
exaly  

Anti-inflammatory effects and specificity of L-156,602: comparison of effects on concanavalin A and zymosan-induced footpad edema, and contact sensitivity response

Immunopharmacology, 1995
Ryohei F Tsuji   +2 more
exaly  

Antitumor activity of CKD-602, a camptothecin derivative, in a mouse glioma model

Journal of Clinical Neuroscience, 2012
Chae-Yong Kim   +2 more
exaly  
dry eye
therapeutics
pharmacology
previous   19  20  21  22  

Home - About - Disclaimer - Privacy